<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7356537\results\search\zoonosis\results.xml">
  <result pre="epidemiological data related to ACS at the time of the" exact="Covid-19" post="pandemic; and learnings that have emerged so far from"/>
  <result pre="for optimal management of ACS patients with confirmed or suspected" exact="SARS-CoV-2 infection." post="acute coronary syndromes myocardial infarction STEMI Covid-19 infectious disease"/>
  <result pre="or suspected SARS-CoV-2 infection. acute coronary syndromes myocardial infarction STEMI" exact="Covid-19" post="infectious disease respiratory infections pathophysiology percutaneous coronary intervention thrombolysis"/>
  <result pre="30 January 2020, the World Health Organization (WHO) declared the" exact="Covid-19" post="outbreak a public health emergency of international concern, and"/>
  <result pre="might have an increased risk of death [5,6,7]. Moreover, the" exact="Covid-19" post="outbreak has put a lot of pressure on overloaded"/>
  <result pre="in Lombardy (Italy) and more generally in Northern Italy, where" exact="Covid-19" post="has spread very rapidly, causing concern regarding the capacity"/>
  <result pre="and a common guidance on how to handle ACS in" exact="Covid-19" post="and non-Covid-19 patients is needed. The aim of this"/>
  <result pre="some light on those issues, analyzing possible physiopathological links between" exact="Covid-19" post="and ACS and evaluating the best strategy to balance"/>
  <result pre="to balance optimal ACS management and infectious risks related to" exact="Covid-19" post="outbreak. 2. Acute Coronary Syndromes and COVID-19 2.1. Pathophysiology"/>
  <result pre="a two-fold increased risk of AMI in patients with recent" exact="influenza infection" post="or respiratory tract infection; a recent influenza infection, influenza-like"/>
  <result pre="with recent influenza infection or respiratory tract infection; a recent" exact="influenza infection," post="influenza-like illness, or other respiratory tract infection was significantly"/>
  <result pre="Vejpongsa et al. also showed that AMI patients with concomitant" exact="influenza infection" post="or other viral respiratory infections were less likely to"/>
  <result pre="highlighted and related to what is currently happening during this" exact="Covid-19" post="pandemic, given that patients infected with SARS-CoV-2 virus seem"/>
  <result pre="between severe acute respiratory syndromes, thrombophilia, and subsequently ACS. Additionally," exact="Middle East respiratory syndrome" post="(MERS), which was first reported in 2012 in Saudi"/>
  <result pre="lacking. Alhogbani reported a case of a 60-year-old patient with" exact="MERS coronavirus" post="(MERS-CoV) infection who presented with respiratory symptoms, chest pain,"/>
  <result pre="with Covid-19: What We Know Although the clinical manifestations of" exact="Covid-19" post="are dominated by respiratory symptoms, evidence of myocardial injury"/>
  <result pre="may have a relevant role in worsening clinical outcomes in" exact="Covid-19" post="patients, even without clear evidence of myocardial ischemia. Indeed,"/>
  <result pre="Shi et al., conducted on a cohort of 416 consecutive" exact="Covid-19" post="patients in Wuhan, China, cardiac injury was found in"/>
  <result pre="that cTnI values were significantly increased in patients with severe" exact="SARS-CoV-2 infection" post="compared to those with milder forms of disease [68]."/>
  <result pre="onset of acute myocardial injury related to myocardial ischemia in" exact="SARS-CoV-2 infection" post="have been proposed. Some of them may resemble the"/>
  <result pre="differential diagnosis in many cases. Furthermore, specific damage caused by" exact="SARS-CoV-2 infection" post="might be related to angiotensin-converting enzyme 2 (ACE2) receptors,"/>
  <result pre="Where did All the STEMIs Go? The relevant impact of" exact="Covid-19" post="pandemic is related to the diagnosis and management of"/>
  <result pre="catheterizations). The EMS is now focused on dealing with the" exact="Covid-19" post="outbreak, so less resources are available to cope with"/>
  <result pre="staff, who are either sick or committed to handling the" exact="Covid-19" post="emergency. In order to avoid SARS-CoV-2 spreading, on 8"/>
  <result pre="1 of those should be dedicated to suspected or diagnosed" exact="Covid-19" post="patients, so that the most appropriate protocol can be"/>
  <result pre="between risks related to untimely treatment of ACS patients and" exact="SARS-CoV-2 infection" post="control has become a global challenge. Commonly, regional reperfusion"/>
  <result pre="[81]. Despite this clinical evidence, to cope with the abrupt" exact="Covid-19" post="outbreak, case decisions were individualized at the beginning of"/>
  <result pre="STEMI patients, thrombolytic therapy was recommended over primary PCI if" exact="Covid-19" post="was confirmed or could not be excluded within a"/>
  <result pre="short time, while for NSTEMIâ€&quot;UA, the priority was to exclude" exact="SARS-CoV-2 infection" post="first, since door-to-balloon time is less crucial in those"/>
  <result pre="are undoubtedly useful for minimizing and controlling the spread of" exact="SARS-CoV-2 infection," post="but data on the outcomes of ACS patients are"/>
  <result pre="a first therapy to treat STEMI in confirmed or suspected" exact="Covid-19" post="patients are not associated with worse outcomes. Indeed, despite"/>
  <result pre="thrombolysis. Stefanini et al. performed a retrospective analysis on 28" exact="Covid-19" post="patients who were admitted for STEMI: they found that"/>
  <result pre="PCI were reported among more than 900 patients admitted for" exact="SARS-CoV-2 infection," post="as of May 5, 2020, suggesting a possible link"/>
  <result pre="first case series from New York City (USA) described 18" exact="Covid-19" post="patients with ST-segment elevation indicating potential AMI; among those"/>
  <result pre="(AHA) published guidance on the management of AMI during the" exact="Covid-19" post="pandemic in the US [89,90]. These guidelines state that"/>
  <result pre="although door-to-balloon times are expected to be longer during the" exact="Covid-19" post="pandemic, a primary PCI strategy should remain the first"/>
  <result pre="feasibility of performing PCI in facilities approved for treatment of" exact="Covid-19" post="patients, avoiding potentially harmful thrombolysis, in compliance with adequate"/>
  <result pre="in American guidelines on the management of AMI during the" exact="Covid-19" post="pandemic [89]. An efficacious strategy could be to organize"/>
  <result pre="Interventional Cardiology (CAIC) announced the formation of the North American" exact="Covid-19" post="ST-Segment Elevation Myocardial Infarction Registry (NACMI) [92], which hopefully"/>
  <result pre="are needed to detect and characterize patients with STEMI and" exact="Covid-19" post="and to optimize treatment. 3.3. Organization Issues for Workers"/>
  <result pre="that device times in catheterization labs were higher during the" exact="Covid-19" post="outbreak when compared to 2018â€&quot;2019 times during office and"/>
  <result pre="conducted by Cao et al., hospitalized adult patients with severe" exact="Covid-19" post="showed no benefit with lopinavirâ€&quot;ritonavir treatment beyond standard care,"/>
  <result pre="health care utilization, or quality of life in patients with" exact="Covid-19" post="using aspirin and other non-steroidal anti-inflammatory drugs (NSAIDS) has"/>
  <result pre="low-dose aspirin can be safely used as antiplatelet drug in" exact="Covid-19" post="patients. Additionally, atorvastatin and rosuvastatin should be started at"/>
  <result pre="eventually be related to myocardial injury. Antivirals drugs used for" exact="SARS-CoV-2 infection" post="treatment may have potential interactions with oral anticoagulants (OACs)."/>
  <result pre="moreover, the first evidence showed decreased mortality in most severe" exact="Covid-19" post="patients with coagulopathy [111]. Drugs that are potentially useful"/>
  <result pre="summarized in Table 4. 4. Conclusions Despite being eclipsed by" exact="Covid-19" post="outbreak, acute coronary syndromes are still a major cause"/>
  <result pre="especially because of the possible physiopathological links (currently unexplored) with" exact="SARS-CoV-2 infection." post="Given the limited heterogeneity of data published in recent"/>
  <result pre="in recent months, the potential overlapping symptomatology between ACS and" exact="SARS-CoV-2 infection," post="and the underestimation of ACS cases during Covid-19 outbreak,"/>
  <result pre="and SARS-CoV-2 infection, and the underestimation of ACS cases during" exact="Covid-19" post="outbreak, more reliable data are needed to estimate the"/>
  <result pre="pandemic. Although reports to date suggest that cTn elevation in" exact="Covid-19" post="may be related more to myocardial injury or type"/>
  <result pre="to properly understand all mechanisms that may induce ACS in" exact="SARS-CoV-2 infection." post="All efforts made during the last decades to develop"/>
  <result pre="be forgotten. Specific protocols to balance infective risks related to" exact="Covid-19" post="and optimal ACS management should be implemented (especially STEMI),"/>
  <result pre="expert commentary on how to manage ischemic patients during the" exact="Covid-19" post="pandemic due to their expertise in treating coronary artery"/>
  <result pre="myocardial involvement, and on infectious risk in ischemic patients during" exact="Covid-19" post="pandemic due to his expertise in infectious disease. G.B.-Z.,"/>
  <result pre="ChinaJAMA Cardiol.202010.1001/jamacardio.2020.095032211816 7.GuoT.FanY.ChenM.WuX.ZhangL.HeT.WangH.WanJ.WangX.LuZ.Cardiovascular implications of fatal outcomes of patients with" exact="coronavirus disease 2019" post="(COVID-19)JAMA Cardiol.202010.1001/jamacardio.2020.101732219356 8.RemuzziA.RemuzziG.COVID-19 and Italy: What next?Lancet20203951225122810.1016/S0140-6736(20)30627-932178769 9.EisenA.GiuglianoR.P.BraunwaldE.Updates on"/>
  <result pre="http://www.emro.who.int/health-topics/mers-cov/mers-outbreaks.html(accessed on 16 April 2020) 56.BadawiA.RyooS.G.Prevalence of comorbidities in the" exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV): A systematic review and meta-analysisInt. J. Infect."/>
  <result pre="meta-analysisInt. J. Infect. Dis.20164912913310.1016/j.ijid.2016.06.01527352628 57.MatsuyamaR.NishiuraH.KutsunaS.HayakawaK.OhmagariN.Clinical determinants of the severity of" exact="Middle East respiratory syndrome" post="(MERS): A systematic review and meta-analysisBMC Public Health20161610.1186/s12889-016-3881-4 58.ParkJ.E.JungS.KimA.MERS"/>
  <result pre="cardiovascular systemNat. Rev. Cardiol.20201725926010.1038/s41569-020-0360-532139904 68.LippiG.LavieC.J.Sanchis-GomarF.Cardiac troponin I in patients with" exact="coronavirus disease 2019" post="(COVID-19): Evidence from a meta-analysisProg. Cardiovasc. Dis.202010.1016/j.pcad.2020.03.00132169400 69.ClerkinK.J.FriedJ.A.RaikhelkarJ.SayerG.GriffinJ.M.MasoumiA.JainS.S.BurkhoffD.KumaraiahD.RabbaniL.R.et al.Coronavirus"/>
  <result pre="76.De FilippoO.Dâ€™AscenzoF.AngeliniF.BocchinoP.P.ConrottoF.SagliettoA.SeccoG.G.CampoG.GalloneG.VerardiR.et al.Reduced rate of hospital admissions for ACS during" exact="Covid-19" post="outbreak in northern ItalyN. Engl. J. Med.202010.1056/NEJMc200916632343497 77.TamC.C.F.CheungK.S.LamS.WongA.YungA.SzeM.LamY.M.ChanC.TsangT.C.TsuiM.et al.Impact"/>
  <result pre="outbreak in northern ItalyN. Engl. J. Med.202010.1056/NEJMc200916632343497 77.TamC.C.F.CheungK.S.LamS.WongA.YungA.SzeM.LamY.M.ChanC.TsangT.C.TsuiM.et al.Impact of" exact="coronavirus disease 2019" post="(COVID-19) outbreak on ST-segment-elevation myocardial infarction care in Hong"/>
  <result pre="immunoglobulinEur. Heart J.202010.1093/eurheartj/ehaa190 87.InciardiR.M.LupiL.ZacconeG.ItaliaL.RaffoM.TomasoniD.CaniD.S.CeriniM.FarinaD.GavazziE.et al.Cardiac involvement in a patient with" exact="coronavirus disease 2019" post="(COVID-19)JAMA Cardiol.202010.1001/jamacardio.2020.109632219357 88.BangaloreS.SharmaA.SlotwinerA.YatskarL.HarariR.ShahB.IbrahimH.FriedmanG.H.ThompsonC.AlviarC.L.et al.ST-segment elevation in patients with covid-19â€&quot;A"/>
  <result pre="Are we taking care of healthcare workers in the Italian" exact="Covid-19" post="outbreak?J. Hosp. Infect.202010.1016/j.jhin.2020.04.04532387745 97.ChuC.M.ChengV.C.C.HungI.F.N.WongM.M.L.ChanK.H.ChanK.S.KaoR.Y.T.PoonL.L.M.WongC.L.P.GuanY.et al.Role of lopinavir/ritonavir in the"/>
  <result pre="for patients, health care workers, and health systems during the" exact="coronavirus disease 2019" post="(COVID-19) pandemicJ. Am. Coll. Cardiol.202010.1016/j.jacc.2020.03.031 102.LittleP.Non-steroidal anti-inflammatory drugs and"/>
  <result pre="in patients with covid-19N. Engl. J. Med.20203821653165910.1056/NEJMsr200576032227760 108.SandersJ.M.MonogueM.L.JodlowskiT.Z.CutrellJ.B.Pharmacologic treatments for" exact="coronavirus disease 2019" post="(COVID-19): A reviewJAMA202010.1001/jama.2020.6019 109.PetersonD.Van ErmenA.Increased warfarin requirements in a"/>
  <result pre="Pharmacol.20174211511810.1111/jcpt.12475 111.TangN.BaiH.ChenX.GongJ.LiD.SunZ.Anticoagulant treatment is associated with decreased mortality in severe" exact="coronavirus disease 2019" post="patients with coagulopathyJ. Thromb. Haemost.202010.1111/jth.1481732220112 112.ValgimigliM.BuenoH.ByrneR.A.ColletJ.P.CostaF.JeppssonA.JÃ¼niP.KastratiA.KolhP.MauriL.et al.2017 ESC focused"/>
  <result pre="Kwong et al., 2018, New England Journal of Medicine [43]" exact="Influenza" post="A/B, RSV, adenovirus, CoV, enterovirus (including rhinovirus), HPIV, and"/>
  <result pre="= 19,045 Warren-Gash et al., 2013, British Medical Journal [44]" exact="Influenza" post="A H1N1 Respiratory tract infection developed within one month"/>
  <result pre="= 123 Ruane et al., 2017, Internal Medicine Journal, [50]" exact="Influenza" post="Association between STEMI and influenza epidemic Angiographically confirmed STEMI"/>
  <result pre="HPIV: human parainfluenza virus; ICD: international classification of diseases; MERS:" exact="Middle East respiratory syndrome;" post="MI: myocardial infarction; NA: not available, NSTEMI: myocardial infarction"/>
  <result pre="artery diseaseâ€&quot;evidence and potential interactions with drugs used to treat" exact="SARS-CoV-2 infection." post="Therapy Potential Interactions Evidence Notes P2Y12 inhibitor: -Clopidogrel -Ticagrelor"/>
  <result pre="Aspirin - Lack of evidence on discontinuation of aspirin in" exact="Covid-19" post="patients. Low-dose aspirin can be assumed to be safe"/>
  <result pre="can be assumed to be safe as antiplatelet drug in" exact="Covid-19" post="patients [103]. Statins: -Atorvastatin -Rosuvastatin -Lovastatin -Simvastatin Lopinavirâ€&quot;Ritonavir When"/>
  <result pre="the use of these medications with an increased risk of" exact="Covid-19" post="acquisition or illness severity [108]. Abrupt withdrawal in high-risk"/>
  <result pre="[107,108]. Heparin - First evidences showed decreased mortality in severe" exact="Covid-19" post="patients with coagulopathy [111]. Given the interactions between some"/>
 </snippets>
</snippetsTree>
